Clik here to view.
Terumo BCT与Banco de Sangre de Servicios Mutuos就血液处理计划展开合作，采用试验器材协助改善血液供应的安全性
科罗拉多州莱克伍德 (美国商业资讯)–鉴于对基孔肯雅病毒(CHIKV)和登革热在公共卫生方面的担忧，Terumo...
View ArticleClik here to view.
Clik here to view.
Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE®...
View ArticleClik here to view.
Right.Brain Foundation e.V. Provides Advanced Navigation System to New...
MUNICH King Norodom Sihamoni and Prime Minister Hun Sen of Cambodia attended the inauguration of the first full-scale public Neurology Center that includes a 90-bed, $10.8 million dollar treatment...
View ArticleClik here to view.
CSTが「最も優れた抗体」および「最も有益なウェブサイト」の部門でライフサイエンス・インダストリー・アワードを受賞
ワシントン （ビジネスワイヤ）– 抗体、キット、サービスを提供する一流企業のセル・シグナリング・テクノロジー（CST）は本日、「最も優れた抗体」（Best Antibodies）および「最も有益なウェブサイト」（Most Useful Website）の2部門でライフサイエンス・インダストリー・アワード（Life Science Industry...
View ArticleClik here to view.
Clik here to view.
Merck Submits New Drug Application to the Japanese Pharmaceuticals and...
WHITEHOUSE STATION, N.J. Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its...
View ArticleClik here to view.
Teduglutide Granted Orphan Drug Designation in Japan
BEDMINSTER, N.J. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today...
View ArticleClik here to view.
Clik here to view.
昆泰在韩国获得最佳职场称号
韩国首尔 (美国商业资讯)–昆泰(Quintiles)今天宣布，该公司在由最佳职场研究所(Great Place to Work® Institute)主持的评选中被选为韩国最佳职场之一；这是昆泰韩国(Quintiles Korea)首次获此殊荣，并进入最佳职场研究所授予类似奖励的全球其他昆泰办事处的行列。 昆泰韩国是最高级别“大奖”(Grand...
View ArticleClik here to view.
クインタイルズ、韓国で「最も働きがいのある会社」に選ばれる
韓国ソウル 韓国ソウル （ビジネスワイヤ） — クインタイルズは本日、グレート・プレース・トゥ・ワーク・インスティテュートから「韓国の最も働きがいのある会社」の1つに選ばれたと発表しました。クインタイルズ韓国がこの賞を獲得したのは今回が初めてで、グレート・プレース・トゥ・ワーク・インスティテュートから同様の賞を獲得している世界各地のその他多くのクインタイルズのオフィスに加わります。...
View ArticleClik here to view.
R-Tech Ueno Received Orphan Drug Designation for Unoprostone Isopropyl...
TOKYO R-Tech Ueno (JASDAQ:4573): R-Tech Ueno, Ltd. today announced that we have officially received the Orphan Drug Designation from the Ministry of Health, Labour and Welfare (MHLW) for Unoprostone...
View ArticleClik here to view.
Global and China Insulin Market to Reach US$32.24 Billion by 2019:...
ALBANY, New York Transparency Market Research has recently added a latest report titled as “Global and China Insulin Market - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and...
View ArticleClik here to view.
ResolutionMD® Receives Certification for Web and Mobile Diagnosis in Australia
CALGARY Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today that ResolutionMD® has received certification from the...
View ArticleClik here to view.
PENTAX Medical Launches New ENT Videoscope Solution
HAMBURG, Germany PENTAX Medical launches today the new VIVIDEO system, an advanced ENT videoscope solution, in the European, Middle Eastern and African (EMEA) Markets. This endoscopy system consists...
View ArticleClik here to view.
株式会社東芝が日本で新たに開始するゲノム解析サービスのためにアフィメトリクス社のAxiomプラットフォームを採用
カリフォルニア州サンタクララ発 （ビジネスワイヤ） — アフィメトリクス社（NASDAQ：AFFX）は、株式会社東芝（TYO：6502）ヘルスケア社が新たに開始するゲノム解析サービスのプラットフォームとして、Axiom®ジェノタイピングソリューションが採用されたことを発表します。当社は、株式会社東芝と協働し、Axiomプラットフォーム技術を用いて｢ジャポニカアレイ®...
View ArticleClik here to view.
Toshiba Corporation Selects Affymetrix Axiom Platform for Its Newly Launched...
SANTA CLARA, Calif. Affymetrix (NASDAQ: AFFX) announces its Axiom® Genotyping Solution platform has been selected by Toshiba Corporation’s (TYO: 6502) Healthcare Company as the platform for its...
View ArticleClik here to view.
Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the...
View ArticleClik here to view.
HanAll Biopharma Co., Ltd. and Open Monoclonal Technology Announce Collaboration
SEOUL, South Korea & PALO ALTO, Calif. HanAll BioPharma Co., Ltd. (HanAll), a public Korean biopharmaceutical company and leader in development of novel biologics and new chemical entities in...
View ArticleClik here to view.
Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
TOKYO Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5...
View Article